r.erdogan
TL2 Moderator · Faro
Contributes reviews on supplier material. Based in Faro.
Joined 22 January 2025 · last posted 2d
88 posts, newest first. Showing up to 150.
-
Which categories are strict and which are relaxed, honestly Replied, post #54 · Start Here › Welcome · 26 Jul 2026 · 25 likes Coming back to post #52, because the follow-up matters more than the original answer. Welcome. The orientation materials are pinned at the top of this category and they…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #34 · Clinical › Prescriber conversations · 22 Jul 2026 · 17 likes I read post #32 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Asking a follow-up: new topic or new reply? Replied, post #56 · Start Here › How to Ask · 16 Jul 2026 · 10 likes Picking up post #53: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Transit times by route, from a logged dataset Replied, post #9 · Sourcing › Logistics · 14 Jul 2026 · 9 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Submitting a sample: the process end to end Replied, post #81 · Sourcing › Independent verification · 14 Jul 2026 · 20 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Common supplements people ask about, assessed one at a time Replied, post #40 · Practice › Interactions · 13 Jul 2026 · 30 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #32 · Clinical › Comorbidities · 11 Jul 2026 · 19 likes Picking up post #29: that is the part I would want checked first. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was…
-
The most useful thing you learned here that was not the answer you came for Replied, post #57 · Lounge › Off topic · 9 Jul 2026 · 14 likes This follows post #54 rather than contradicting it. Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the…
-
Revisiting: The best-written scientific paper you have read Replied, post #75 · Lounge › Off topic · 7 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #38 · Nutrition & Training › Protein & intake · 6 Jul 2026 · 20 likes On post #34 — agreed on the reasoning, with one qualification. Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food…
-
Programming during a large energy deficit Replied, post #27 · Nutrition & Training › Resistance training · 28 Jun 2026 · 5 likes Worth separating two things that post #23 runs together. Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly…
-
What a reversed-phase purity number actually is Replied, post #8 · Analytics › HPLC & UHPLC · 28 Jun 2026 · 0 likes post #7 answers the question as asked. The question underneath it is different. Method validation is the demonstration that a method can separate the compound from its…
-
Reading a home test result without over-claiming Replied, post #79 · Analytics › Home & field testing · 14 Jun 2026 · 1 like False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
Racemisation and why it is invisible to a mass measurement Replied, post #103 · Analytics › Impurities & related substances · 14 Jun 2026 · 25 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
Micronutrient adequacy at low total intake Replied, post #50 · Nutrition & Training › Protein & intake · 10 Jun 2026 · 0 likes post #49 is right about the mechanism and I think understates the practical bit. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #46 · Analytics › Home & field testing · 9 Jun 2026 · 1 like post #45 answers the question as asked. The question underneath it is different. Sample handling matters: if a sample is contaminated or degraded before testing, the…
-
Submitting a sample: the process end to end Replied, post #6 · Sourcing › Independent verification · 7 Jun 2026 · 0 likes Coming back to post #4, because the follow-up matters more than the original answer. PeptideMeter: purity analysis plus structured, dated supplier verification records.…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #103 · Sourcing › Red flags · 6 Jun 2026 · 14 likes Picking up post #100: that is the part I would want checked first. Safety documentation absent: a supplier that cannot provide information about sterility testing,…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #16 · Evidence › Journal club · 4 Jun 2026 · 5 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #65 · Practice › Storage & stability · 2 Jun 2026 · 0 likes On post #61 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Electrolyte supplements: which ones do anything Replied, post #15 · Nutrition & Training › Hydration & electrolytes · 24 May 2026 · 0 likes The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie deficit, and inadequate sleep are more common causes of fatigue…
-
Revisiting: Patterns that reliably precede a problem, documented Replied, post #17 · Sourcing › Red flags · 22 May 2026 · 3 likes Worth separating two things that post #13 runs together. Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #18 · Research Methods › N-of-1 designs · 19 May 2026 · 10 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #5 · Sourcing › Vendor reports · 17 May 2026 · 2 likes post #4 is right about the mechanism and I think understates the practical bit. Temporal patterns: if results from a supplier were good two years ago but have…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #24 · Wellbeing › Sleep · 29 Apr 2026 · 3 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Journal club: is percentage weight change the right endpoint? Replied, post #89 · Evidence › Journal club · 21 Apr 2026 · 0 likes Coming back to post #87, because the follow-up matters more than the original answer. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes.…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #50 · Practice › Reconstitution · 21 Apr 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: When a red flag was a misunderstanding, and the retraction Replied, post #3 · Sourcing › Red flags · 20 Apr 2026 · 12 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #2 · Practice › Reconstitution · 28 Mar 2026 · 7 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Light exposure: how much protection is proportionate? Started this topic · Practice › Storage & stability · 21 Mar 2026 · 10 likes The question in the title: Light exposure: how much protection is proportionate? I will give what I have already checked below so nobody repeats it. A question about…
-
Moderation log format change Replied, post #36 · Meta › Announcements · 15 Mar 2026 · 12 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Maintainer handover: how it works Replied, post #29 · Meta › Wiki maintenance · 4 Mar 2026 · 12 likes Scope creep: if a page is attempting too much, suggesting it split into multiple pages can improve clarity.
-
[2026 update] Journal club: PIONEER 6 as a safety trial Replied, post #16 · Evidence › Journal club · 1 Mar 2026 · 0 likes Worth separating two things that post #12 runs together. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #31 · Outcomes › Body composition · 22 Feb 2026 · 7 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #33 · Analytics › Mass spectrometry · 13 Feb 2026 · 20 likes post #32 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #34 · Data & Tools › Calculators · 29 Jan 2026 · 4 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Trifluoroacetate content and its consequences Replied, post #24 · Analytics › Impurities & related substances · 26 Jan 2026 · 30 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #42 · Documentation › Wiki requests · 17 Jan 2026 · 0 likes This follows post #39 rather than contradicting it. Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #27 · Practice › Side effects · 15 Jan 2026 · 3 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
What to include when your question involves a chromatogram Replied, post #44 · Start Here › How to Ask · 15 Jan 2026 · 5 likes post #43 answers the question as asked. The question underneath it is different. Asking a follow-up: new topic or reply in the old one? If the answer depends on the…
-
A partial dose because the pen emptied mid-injection Replied, post #115 · Practice › Administration · 11 Jan 2026 · 3 likes I read post #113 twice before replying, because I had assumed the opposite. A genuinely late dose: the labelling generally says that if the next dose is more than a…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #41 · Start Here › How to Ask · 12 Dec 2025 · 0 likes Worth separating two things that post #37 runs together. Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is…
-
DXA precision and the least significant change for lean mass Replied, post #20 · Outcomes › Body composition · 25 Nov 2025 · 1 like This follows post #17 rather than contradicting it. Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around…
-
Prescription requirements and telehealth models Replied, post #16 · Sourcing › Regulatory · 16 Nov 2025 · 0 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #89 · Evidence › Journal club · 6 Nov 2025 · 22 likes I read post #87 twice before replying, because I had assumed the opposite. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #113 · Compounds › Tirzepatide · 24 Oct 2025 · 4 likes post #112 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Reused chromatograms across lots: how to spot it Started this topic · Analytics › COA interpretation · 23 Oct 2025 · 25 likes On the subject in the title: Reused chromatograms across lots: how to spot it Working notes rather than a conclusion. A documentation question rather than an analytical…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #51 · Compounds › Oral incretins · 19 Oct 2025 · 0 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #121 · Practice › Side effects · 5 Oct 2025 · 0 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
Micronutrient adequacy at low total intake — does this still hold? Replied, post #2 · Nutrition & Training › Protein & intake · 3 Oct 2025 · 10 likes On the opening post — agreed on the reasoning, with one qualification. Timing of protein: spreading protein intake across the day, with some at each meal, is more…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #48 · Practice › Storage & stability · 9 Sep 2025 · 10 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Asking about a compound your prescriber has not heard of Replied, post #144 · Clinical › Prescriber conversations · 31 Aug 2025 · 2 likes Coming back to post #142, because the follow-up matters more than the original answer. How to ask for what you need: rather than "should I take this", frame it as "I…
-
What a purity-only report leaves out Replied, post #2 · Sourcing › Independent verification · 29 Aug 2025 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
When a preprint is the best available evidence and we say so Replied, post #94 · Evidence › Preprints · 24 Aug 2025 · 0 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #91 · Evidence › Journal club · 22 Aug 2025 · 10 likes I read post #89 twice before replying, because I had assumed the opposite. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #62 · Devices › Cold chain · 12 Aug 2025 · 24 likes post #61 is right about the mechanism and I think understates the practical bit. Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #6 · Compounds › Other compounds · 25 Jul 2025 · 17 likes I read post #4 twice before replying, because I had assumed the opposite. This subcategory exists because some people will research compounds outside the main groups…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #146 · Compounds › Tirzepatide · 25 Jul 2025 · 12 likes I read post #144 twice before replying, because I had assumed the opposite. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #18 · Pharmacology › Receptor biology · 20 Jul 2025 · 12 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Asking about a compound your prescriber has not heard of Replied, post #89 · Clinical › Prescriber conversations · 9 Jul 2025 · 21 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #37 · Clinical › Special populations · 8 Jul 2025 · 28 likes I read post #35 twice before replying, because I had assumed the opposite. Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #41 · Clinical › Comorbidities · 27 May 2025 · 6 likes post #40 answers the question as asked. The question underneath it is different. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea…
-
Pre-registering a personal experiment, seriously Replied, post #26 · Research Methods › N-of-1 designs · 27 May 2025 · 4 likes Picking up post #23: that is the part I would want checked first. Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the…
-
Reading a trial's population section before its results — does this still hold? Replied, post #152 · Evidence › Trials · 27 May 2025 · 24 likes Picking up post #149: that is the part I would want checked first. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #101 · Access › Pricing · 15 May 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #67 · Practice › Reconstitution · 10 May 2025 · 4 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #23 · Practice › Dosing & titration · 27 Apr 2025 · 2 likes This follows post #20 rather than contradicting it. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature…
-
Triple agonism: additive, synergistic, or neither? Replied, post #38 · Compounds › Retatrutide · 20 Apr 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Residual solvents and scavengers: what is looked for Replied, post #6 · Analytics › Impurities & related substances · 23 Mar 2025 · 5 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #67 · Sourcing › Red flags · 18 Mar 2025 · 22 likes post #66 answers the question as asked. The question underneath it is different. Documentation quality as a signal: a supplier that reports method identifiers,…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #57 · Documentation › Doc review · 13 Mar 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Washout: how long is long enough, and for what purpose Replied, post #5 · Pharmacology › Pharmacokinetics · 19 Feb 2025 · 32 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Adjudicated events and why the definition matters — the long version Replied, post #5 · Evidence › Trials · 8 Feb 2025 · 5 likes Worth separating two things that the opening post runs together. Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #44 · Compounds › Semaglutide · 26 Nov 2024 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Telehealth prescribing models in the US Replied, post #26 · Regional › North America · 24 Nov 2024 · 8 likes post #25 is right about the mechanism and I think understates the practical bit. Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #83 · Clinical › Prescriber conversations · 21 Nov 2024 · 6 likes This follows post #80 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #68 · Clinical › Prescriber conversations · 16 Nov 2024 · 0 likes On post #64 — agreed on the reasoning, with one qualification. Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes,…
-
Transporting a vial for a weekend away Replied, post #41 · Practice › Storage & stability · 8 Nov 2024 · 10 likes This follows post #38 rather than contradicting it. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #19 · Compounds › Cagrilintide & amylin analogues · 6 Nov 2024 · 0 likes This follows post #16 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Buffers, pH and why a formulation is a formulation Replied, post #6 · Pharmacology › Formulation chemistry · 27 Oct 2024 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #87 · Analytics › COA interpretation · 17 Oct 2024 · 0 likes Worth separating two things that post #83 runs together. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The…
-
Progressive overload when the scale is falling — one year on Replied, post #159 · Nutrition & Training › Resistance training · 14 Oct 2024 · 3 likes Coming back to post #157, because the follow-up matters more than the original answer. Frequency: three sessions per week of full-body training is easier to maintain…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #41 · Analytics › Method validation · 28 Sep 2024 · 6 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #108 · Nutrition & Training › Hydration & electrolytes · 22 Sep 2024 · 24 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #37 · Analytics › Impurities & related substances · 5 Sep 2024 · 10 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #22 · Compounds › Oral incretins · 30 Aug 2024 · 13 likes Worth separating two things that post #18 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Correlation in a self-tracked dataset: what it can support Replied, post #13 · Research Methods › Statistics · 20 Aug 2024 · 2 likes Power and sample size: a study might be too small to detect a real effect (low power). Sample size calculations help determine how many participants are needed to…
-
Promotion criteria, and the one that stops most nominations Replied, post #30 · Documentation › Doc review · 3 Aug 2024 · 8 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…